Location & dates EMBL Heidelberg, Germany 8 - 10 Dec 2019
Deadlines Registration closed Abstract submission closed
organiser_WGC

Coronavirus information for participants

The onsite course and conference programme at EMBL has been paused until the end of June 2020.


We aim to continue offering our advanced training for the scientific community however we safely can. While some events have been cancelled, many have been rescheduled for a later date and others will be delivered as virtual events.


Registration is open for onsite courses and conferences starting after 1 July and for the virtual events. All registration fees for any events which don’t take place due to the COVID-19 disruption are fully refundable.


More information for participants of events at EMBL Heidelberg can be found here.

Bus schedule, poster listing, onsite logistics information are now available for download.

Conference Overview

In association with Wellcome Genome Campus, we are pleased to announce the annual conference on Target Validation using Genomics and Informatics.

In the past few years, exceptional progress has been made in making available thousands of DNA variants that are robustly associated with clinically relevant human traits.  This is providing a rich source of molecular points for drug discovery and a deeper understanding of human biology. This meeting will highlight advances in the use of high-throughput methods and functional validation techniques that can influence the selection of new drug targets and the development of precision medicine. We will discuss the advancements and challenges of using gene editing (e.g. CRISPR) in human cells to develop validation approaches. The programme will also present recent advances in visualisation techniques, computational tools and new platforms that provide data integration and can enhance the user experience.

This meeting will bring together researchers based in academia and industry to focus on the opportunities and challenges for genomics in drug discovery. Multi-omics (e.g. genomics, proteomics, transcriptomics), epidemiology, molecular biology and computational approaches will be covered, focusing on the contributions of these methods to target validation.

Session Topics

  • Genetics
  • Case studies
  • Genome editing for target validation
  • Relevant models for target validation
  • Computational methods and analysis

 

EMBL Courses and Conferences are kindly supported by our Corporate Partnership Programme

Founder partners

  • Leica logo
  • Olympus logo

Corporate partners

  • 10x Genomics_120x82
  • Becton Dickinson logo
  • Bio-Rad logo
  • Boehringer Ingelheim logo
  • Eppendorf logo
  • GSK logo
  • Milteniy Biotec logo
  • Stilla logo
  • ThermoFisher logo

Associate partners

  • Merck logo
  • New England Biolabs logo
  • Nikon logo
  • Promega logo
  • Roche logo
  • Sanofi logo
  • Sartorius logo